Young Kwang Chae

Path toward Precision Oncology: Review of Targeted Therapy Studies and Tools to Aid in Defining “Actionability” of a Molecular Lesion and Patient Management Support

Razelle Kurzrock, Young Kwang Chae, Alan P Pan, 2017, Molecular Cancer Therapeutics.

A Promoter Methylation Pattern in the N-Methyl-d-Aspartate Receptor 2B Gene Predicts Poor Prognosis in Esophageal Squamous Cell Carcinoma

Keishi Yamashita, David Sidransky, Joseph A Califano, 2007, Clinical Cancer Research.

Genomic landscape of DNA repair genes in cancer

Jason Kaplan, Young Kwang Chae, L. Platanias, 2016, Oncotarget.

Two birds with one stone: octreotide treatment for acromegaly and breast cancer.

Funda Meric-Bernstam, Young Kwang Chae, F. Meric-Bernstam, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

EGFR Fusions as Novel Therapeutic Targets in Lung Cancer.

Jens Meiler, Taofeek K Owonikoko, Jonathan H Sheehan, 2016, Cancer discovery.

Concordance of Genomic Alterations by Next-Generation Sequencing in Tumor Tissue versus Circulating Tumor DNA in Breast Cancer

Sarika Jain, Massimo Cristofanilli, Nike Beaubier, 2017, Molecular Cancer Therapeutics.

Systematic review and meta-analysis of selected toxicities of approved ALK inhibitors in metastatic non-small cell lung cancer

Corinne Miller, Alfred Rademaker, Young Kwang Chae, 2018, Oncotarget.

Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application

Massimo Cristofanilli, Young Kwang Chae, P. Hammerman, 2016, Oncotarget.